Levamlodipine/Telmisartan
- Generic Name
- Levamlodipine/Telmisartan
Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet
Phase 3
- Conditions
- HypertensionDyslipidemias
- Interventions
- Drug: CKD-828(placebo)Drug: D326Drug: D326(placebo)Drug: D337(placebo)Drug: D013(placebo)Drug: D013
- First Posted Date
- 2020-05-14
- Last Posted Date
- 2020-05-14
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 120
- Registration Number
- NCT04388215
- Locations
- 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of
CKD-828 (80/5mg) Pharmacokinetic Study
- First Posted Date
- 2015-02-09
- Last Posted Date
- 2015-07-08
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 48
- Registration Number
- NCT02358824
- Locations
- 🇰🇷
Kyungpook National University Hospital, Daegu, samdeok-dong, 2-ga 50, samdeok-dong, 2-ga 50 Jung-gu, Korea, Republic of
CKD-828 (80/5mg) Pharmacokinetic Study
- First Posted Date
- 2014-09-26
- Last Posted Date
- 2015-04-10
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 69
- Registration Number
- NCT02250833
- Locations
- 🇰🇷
Kyungpook National University Hospital, Daegu, samdeok-dong, 2-ga 50, samdeok-dong, 2-ga 50 Jung-gu, Korea, Republic of
CKD-828(80/2.5mg) Pharmacokinetic Study_2nd
- First Posted Date
- 2011-05-12
- Last Posted Date
- 2011-06-08
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 67
- Registration Number
- NCT01352689
CKD-828 (40/5mg) Pharmacokinetic Study
- First Posted Date
- 2011-04-22
- Last Posted Date
- 2011-04-28
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 68
- Registration Number
- NCT01340131
- Locations
- 🇰🇷
Inje University Pusan Paik Hospital, Pusan, Korea, Republic of
CKD-828(80/2.5mg) Pharmacokinetic Study
- First Posted Date
- 2010-11-23
- Last Posted Date
- 2011-01-19
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 65
- Registration Number
- NCT01246193
- Locations
- 🇰🇷
Inje Unuversity Pusan Paik Hospital, Pusan, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath